{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:01:09Z","timestamp":1784851269883,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021171","name":"GuangDong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2023A1515220009"],"award-info":[{"award-number":["2023A1515220009"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82373236"],"award-info":[{"award-number":["82373236"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangzhou Basic and Applied Basic Research Foundation","award":["2023A04J2443"],"award-info":[{"award-number":["2023A04J2443"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16165-1","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T05:35:27Z","timestamp":1779773727000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcriptomic analysis of genes in bladder cancer patients with resistance to neoadjuvant chemoimmunotherapy"],"prefix":"10.1186","volume":"26","author":[{"given":"Chunxiao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xincheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhou","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"3","key":"16165_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"5","key":"16165_CR2","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020. Cancer J Clin. 2020;70(5):404\u201323.","journal-title":"Cancer J Clin"},{"issue":"4","key":"16165_CR3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1464-410X.2010.09912.x","volume":"108","author":"FA Yafi","year":"2011","unstructured":"Yafi FA, Aprikian AG, Chin JL, Fradet Y, Izawa J, Estey E, Fairey A, Rendon R, Cagiannos I, Lacombe L, et al. Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience. BJU Int. 2011;108(4):539\u201345.","journal-title":"BJU Int"},{"issue":"9","key":"16165_CR4","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1056\/NEJMoa022148","volume":"349","author":"HB Grossman","year":"2003","unstructured":"Grossman HB, Natale RB, Tangen CM, Speights VO, Vogelzang NJ, Trump DL, deVere White RW, Sarosdy MF, Wood DP Jr., Raghavan D, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003;349(9):859\u201366.","journal-title":"N Engl J Med"},{"issue":"6","key":"16165_CR5","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.euo.2020.06.009","volume":"3","author":"M Rouanne","year":"2020","unstructured":"Rouanne M, Bajorin DF, Hannan R, Galsky MD, Williams SB, Necchi A, Sharma P, Powles T. Rationale and Outcomes for Neoadjuvant Immunotherapy in Urothelial Carcinoma of the Bladder. Eur Urol Oncol. 2020;3(6):728\u201338.","journal-title":"Eur Urol Oncol"},{"key":"16165_CR6","doi-asserted-by":"crossref","unstructured":"Gupta S, Sonpavde G, Weight CJ, McGregor BA, Gupta S, Maughan BL, Wei XX, Gibb E, Thyagarajan B, Einstein DJ. Results from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in muscle invasive bladder cancer (MIBC) undergoing cystectomy. In.: American Society of Clinical Oncology; 2020. https:\/\/clinicaltrials.gov\/study\/NCT03294304.","DOI":"10.1200\/JCO.2020.38.6_suppl.439"},{"issue":"6","key":"16165_CR7","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.eururo.2015.07.009","volume":"68","author":"ER Plimack","year":"2015","unstructured":"Plimack ER, Dunbrack RL, Brennan TA, Andrake MD, Zhou Y, Serebriiskii IG, Slifker M, Alpaugh K, Dulaimi E, Palma N. al: Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer. Eur Urol. 2015;68(6):959\u201367.","journal-title":"Eur Urol"},{"issue":"10","key":"16165_CR8","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1158\/2159-8290.CD-14-0623","volume":"4","author":"EM Van Allen","year":"2014","unstructured":"Van Allen EM, Mouw KW, Kim P, Iyer G, Wagle N, Al-Ahmadie H, Zhu C, Ostrovnaya I, Kryukov GV, O\u2019Connor KW, et al. Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma. Cancer Discov. 2014;4(10):1140\u201353.","journal-title":"Cancer Discov"},{"issue":"7","key":"16165_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/14737140.2020.1784011","volume":"20","author":"RK Jain","year":"2020","unstructured":"Jain RK, Sonpavde G. Neoadjuvant therapy for muscle-invasive bladder cancer. Expert Rev Anticancer Ther. 2020;20(7):603\u201314.","journal-title":"Expert Rev Anticancer Ther"},{"key":"16165_CR10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ebiom.2018.06.011","volume":"35","author":"Z Yang","year":"2018","unstructured":"Yang Z, Zhang R, Ge Y, Qin X, Kang X, Wang Y, Zhang X, Song C, Quan X, Wang H, et al. Somatic FGFR3 Mutations Distinguish a Subgroup of Muscle-Invasive Bladder Cancers with Response to Neoadjuvant Chemotherapy. EBioMedicine. 2018;35:198\u2013203.","journal-title":"EBioMedicine"},{"issue":"6","key":"16165_CR11","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.eururo.2019.02.017","volume":"75","author":"J Kim","year":"2019","unstructured":"Kim J, Kwiatkowski D, McConkey DJ, Meeks JJ, Freeman SS, Bellmunt J, Getz G, Lerner SP. The Cancer Genome Atlas Expression Subtypes Stratify Response to Checkpoint Inhibition in Advanced Urothelial Cancer and Identify a Subset of Patients with High Survival Probability. Eur Urol. 2019;75(6):961\u20134.","journal-title":"Eur Urol"},{"issue":"7693","key":"16165_CR12","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, Kadel EE III, Koeppen H, Astarita JL, Cubas R, et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138.","journal-title":"Nature"},{"issue":"12","key":"16165_CR13","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/s41591-020-1085-z","volume":"26","author":"N van Dijk","year":"2020","unstructured":"van Dijk N, Gil-Jimenez A, Silina K, Hendricksen K, Smit LA, de Feijter JM, van Montfoort ML, van Rooijen C, Peters D, Broeks A, et al. Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial. Nat Med. 2020;26(12):1839\u201344.","journal-title":"Nat Med"},{"issue":"17","key":"16165_CR14","first-page":"i884","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinf (Oxford England). 2018;34(17):i884\u201390.","journal-title":"Bioinf (Oxford England)"},{"issue":"4","key":"16165_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9(4):357\u20139.","journal-title":"Nat Methods"},{"issue":"4","key":"16165_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12(4):357\u201360.","journal-title":"Nat Methods"},{"issue":"3","key":"16165_CR17","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nbt.3122","volume":"33","author":"M Pertea","year":"2015","unstructured":"Pertea M, Pertea GM, Antonescu CM, Chang TC, Mendell JT, Salzberg SL. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol. 2015;33(3):290\u20135.","journal-title":"Nat Biotechnol"},{"issue":"9","key":"16165_CR18","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1038\/nprot.2016.095","volume":"11","author":"M Pertea","year":"2016","unstructured":"Pertea M, Kim D, Pertea GM, Leek JT, Salzberg SL. Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown. Nat Protoc. 2016;11(9):1650\u201367.","journal-title":"Nat Protoc"},{"issue":"17","key":"16165_CR19","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1093\/nar\/gkt646","volume":"41","author":"L Sun","year":"2013","unstructured":"Sun L, Luo H, Bu D, Zhao G, Yu K, Zhang C, Liu Y, Chen R, Zhao Y. Utilizing sequence intrinsic composition to classify protein-coding and long non-coding transcripts. Nucleic Acids Res. 2013;41(17):e166.","journal-title":"Nucleic Acids Res"},{"key":"16165_CR20","doi-asserted-by":"crossref","unstructured":"Kong L, Zhang Y, Ye ZQ, Liu XQ, Zhao SQ, Wei L, Gao G. CPC: assess the protein-coding potential of transcripts using sequence features and support vector machine. Nucleic Acids Res. 2007;35(Web Server issue):W345\u2013349.","DOI":"10.1093\/nar\/gkm391"},{"key":"16165_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323.","journal-title":"BMC Bioinformatics"},{"key":"16165_CR22","doi-asserted-by":"publisher","first-page":"1051063","DOI":"10.3389\/fimmu.2022.1051063","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, He X, Bai Y, Du G, Cai M. Identification and validation of novel biomarkers affecting bladder cancer immunotherapy via machine learning and its association with M2 macrophages. Front Immunol. 2022;13:1051063.","journal-title":"Front Immunol"},{"issue":"6","key":"16165_CR23","first-page":"1217","volume":"45","author":"C Yang","year":"2022","unstructured":"Yang C, Yang Y, Wang W, Zhou W, Zhang X, Xiao Y, Zhang H. CEP55 3\u2019-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p. Cell Oncol (Dordrecht Netherlands). 2022;45(6):1217\u201336.","journal-title":"Cell Oncol (Dordrecht Netherlands)"},{"key":"16165_CR24","doi-asserted-by":"publisher","first-page":"758004","DOI":"10.3389\/fimmu.2021.758004","volume":"12","author":"Y Chen","year":"2021","unstructured":"Chen Y, Wang C, Song J, Xu R, Ruze R, Zhao Y. S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer. Front Immunol. 2021;12:758004.","journal-title":"Front Immunol"},{"issue":"1","key":"16165_CR25","first-page":"107","volume":"31","author":"J Yang","year":"2024","unstructured":"Yang J, Wan S, Zhao M, Cai H, Gao Y, Wang H. Multi-omics Analysis Identifies Hypoxia Subtypes and S100A2 as an Immunosuppressive Factor in Cervical Cancer. Reproductive sciences (Thousand Oaks. Calif). 2024;31(1):107\u201321.","journal-title":"Calif)"},{"issue":"6","key":"16165_CR26","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s41590-023-01498-x","volume":"24","author":"Y Hong","year":"2023","unstructured":"Hong Y, Walling BL, Kim HR, Serratelli WS, Lozada JR, Sailer CJ, Amitrano AM, Lim K, Mongre RK, Kim KD, et al. ST3GAL1 and \u03b2II-spectrin pathways control CAR T cell migration to target tumors. Nat Immunol. 2023;24(6):1007\u201319.","journal-title":"Nat Immunol"},{"issue":"14","key":"16165_CR27","doi-asserted-by":"publisher","first-page":"e2206989","DOI":"10.1002\/adma.202206989","volume":"35","author":"C Zheng","year":"2023","unstructured":"Zheng C, Zhong Q, Song W, Yi K, Kong H, Wang H, Tao Y, Li M, Chen X. Membrane-Fusion-Mediated Multiplex Engineering of Tumor Cell Surface Glycans for Enhanced NK Cell Therapy. Adv Mater (Deerfield Beach Fla). 2023;35(14):e2206989.","journal-title":"Adv Mater (Deerfield Beach Fla)"},{"key":"16165_CR28","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.freeradbiomed.2023.09.017","volume":"208","author":"D Gao","year":"2023","unstructured":"Gao D, Wang R, Gong Y, Yu X, Niu Q, Yang E, Fan G, Ma J, Chen C, Tao Y, et al. CAB39 promotes cisplatin resistance in bladder cancer via the LKB1-AMPK-LC3 pathway. Free Radic Biol Med. 2023;208:587\u2013601.","journal-title":"Free Radic Biol Med"},{"issue":"21","key":"16165_CR29","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1158\/1078-0432.CCR-22-1362","volume":"28","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Ma AH, Zhang H, Lin TY, Xue X, Farrukh H, Zhu S, Shi W, Yuan R, Cao Z, et al. Phototherapy with Cancer-Specific Nanoporphyrin Potentiates Immunotherapy in Bladder Cancer. Clin cancer research: official J Am Association Cancer Res. 2022;28(21):4820\u201331.","journal-title":"Clin cancer research: official J Am Association Cancer Res"},{"issue":"1","key":"16165_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13046-023-02724-y","volume":"42","author":"TW Kao","year":"2023","unstructured":"Kao TW, Bai GH, Wang TL, Shih IM, Chuang CM, Lo CL, Tsai MC, Chiu LY, Lin CC, Shen YA. Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance. J experimental Clin cancer research: CR. 2023;42(1):171.","journal-title":"J experimental Clin cancer research: CR"},{"issue":"3","key":"16165_CR31","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3892\/or.2015.4536","volume":"35","author":"Y Sun","year":"2016","unstructured":"Sun Y, Guan Z, Liang L, Cheng Y, Zhou J, Li J, Xu Y. HIF-1\u03b1\/MDR1 pathway confers chemoresistance to cisplatin in bladder cancer. Oncol Rep. 2016;35(3):1549\u201356.","journal-title":"Oncol Rep"},{"key":"16165_CR32","doi-asserted-by":"publisher","unstructured":"Hao X, Ren Y, Feng M, Wang Q, Wang Y. Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more. Volume 141. Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie; 2021. p. 111798. https:\/\/doi.org\/10.1016\/j.biopha.2021.111798.","DOI":"10.1016\/j.biopha.2021.111798"},{"issue":"9","key":"16165_CR33","doi-asserted-by":"publisher","first-page":"11055","DOI":"10.1021\/acsnano.9b10037","volume":"14","author":"D Kolb","year":"2020","unstructured":"Kolb D, Kolishetti N, Surnar B, Sarkar S, Guin S, Shah AS, Dhar S. Metabolic Modulation of the Tumor Microenvironment Leads to Multiple Checkpoint Inhibition and Immune Cell Infiltration. ACS Nano. 2020;14(9):11055\u201366.","journal-title":"ACS Nano"},{"issue":"1","key":"16165_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13046-022-02447-6","volume":"41","author":"IC Salaroglio","year":"2022","unstructured":"Salaroglio IC, Belisario DC, Akman M, La Vecchia S, Godel M, Anobile DP, Ortone G, Digiovanni S, Fontana S, Costamagna C, et al. Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer. J experimental Clin cancer research: CR. 2022;41(1):243.","journal-title":"J experimental Clin cancer research: CR"},{"issue":"1","key":"16165_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/cas.14229","volume":"111","author":"E Mizushima","year":"2020","unstructured":"Mizushima E, Tsukahara T, Emori M, Murata K, Akamatsu A, Shibayama Y, Hamada S, Watanabe Y, Kaya M, Hirohashi Y, et al. Osteosarcoma-initiating cells show high aerobic glycolysis and attenuation of oxidative phosphorylation mediated by LIN28B. Cancer Sci. 2020;111(1):36\u201346.","journal-title":"Cancer Sci"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16165-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16165-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16165-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T23:12:15Z","timestamp":1784848335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16165-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16165"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16165-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"18 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Medicine Institutional Review Board of Zhujiang Hospital of Southern Medical University (2024-KY-040-01). The Data collection was conducted in accordance with the principles of the Declaration of Helsinki. All participants gave written informed consent for their information and tissue collection with analysis for research purposes.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"890"}}